written on 25.04.2014

Reuters: Allergan broached deal with Shire before Valeant's hostile bid


Allergan may have to buy a foreign company and complete a tax inversion if it wants to dodge a hostile takeover bid by Valeant Pharmaceuticals. But a recent attempt to bulk up didn&#39;t work out so well, <em>Reuters</em>&#39; sources say.